Immunological studies of oxidized superoxide dismutase in patients with systemic lupus erythematosus: Correlation with disease induction and progression

Saudi Medical Journal

Volumn 33, Issue 11, 2012, Pages 1177-1184

  Al Shobaili, Hani A ^a   Rasheed, Zafar ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; HYDROXYL RADICAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BINDING COMPETITION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HUMAN; IMMUNOASSAY; MALE; OXIDATION; SCORING SYSTEM; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET SPECTROSCOPY;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; REACTIVE OXYGEN SPECIES; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE;

EID: 84871899350     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Scofield RH, Kurein RT. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008; 7: 567-573.
2. Wiesik-Szewczyk E, Lacki JK, Feleszko W, Olesinska M. Target therapies in systemic lupus erythematosus: current state of the art. Mini Rev Med Chem 2010; 10: 956-965.
3. Diamond B, Bloom O, Al Abed Y, Kowal C, Huerta PT, Volpe BT. Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. J Intern Med 2011; 269: 36-44.
4. Al-Shobaili HA, Al Robaee A, Alzolibani AA, Rasheed Z. Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: Role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. DisMarkers 2012; 33: 19-34.
5. Otaki N, Chikazawa M, Nagae R, Shimozu Y, Shibata T, Ito S et al. Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies. J Biol Chem 2010; 29: 33834-33842.
6. Al-Shobaili HA, Al Robaee A, Alzolibani A, Khan MI, Rasheed Z. Hydroxyl radical modification of immunoglobulin g generated cross-reactive antibodies: its potential role in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 2011; 4: 11-19.
7. Rasheed Z. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies. Clin Biochem 2008; 41: 663-669.
8. Zhang Q, Ye DQ, Chen GP, Zheng Y. Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin Exp Dermatol 2010; 35: 287-294.
9. Cai P, König R, Khan MF, Qiu S, Kaphalia BS, Ansari GA. Autoimmune response in MRL+/+ mice following treatment with dichloroacetylchloride or dichloroacetic anhydride. Toxicol Appl Pharmacol 2006; 216: 248-255.
10. Rasheed Z, Ahmad R, Rasheed N, Ali R. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 2007; 40: 512-520.
11. Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, et al. Modification of lupus-associated 60-KDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic Biol Med 2005; 38: 719-728.
12. Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB. Antioxidant SOD mimetic prevents NADPH oxidaseinduced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol 2009; 29: 309-331.
13. Mansour RB, Lassoued S, Gargouri B, El Gaid A, Attia H, Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 2008; 37: 103-108.
14. Feletar M, Ibañez D, Urowitz MB, Gladman DD. The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Arthritis Rheum 2003; 48: 2067-2069.
15. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for systemic lupuserythematosus clinical trials: measures of overall disease activity. Arthritis Rheum 2004; 50: 3418-3426.
16. Rasheed Z, Al-Shobaili HA, Alzolibani AA, Ismail Khan M, Tariq Ayub M, Khan MI, et al. Immunological functions of oxidized human immunoglobulin G in type 1diabetes mellitus: its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis Markers 2011; 31: 47-54.
17. Rasheed Z, Ali R. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies. Life Sci 2006; 79: 2320-2328.
18. Richert S, Wehr NB, Stadtman ER, Levine RL. Assessment of skin carbonyl content as a noninvasive measure of biological age. Arch Biochem Biophys 2002; 397: 430-432.
19. Rasheed Z, Khan MW, Ali R. Hydroxyl radical modification of human serum albumin generated cross reactive antibodies. Autoimmunity 2006; 39: 479-488.
20. Rasheed Z, Ahmad R, Ali R. Structure and immunological function of oxidised albumin in lung cancer: its potential role as a biomarker of elevated oxidative stress. Br J Biomed Sci 2009; 66: 67-73.
21. Norheim KB, Jonsson G, Harboe E, Hanasand M, Goransson L, Omdal R. Oxidative stress, as measured by protein oxidation, is increased in primary Sjogren's syndrome. Free Radic Res 2012; 46: 141-146.
22. Sulkowska A. Interaction of drugs with bovine and human serum albumin. J Mol Stru 2002; 614: 227-232.
23. Madian AG, Regnier FE. Proteomic identification of carbonylated proteins and their oxidation sites. J Proteome Res.2010; 9: 3766-3780.
24. Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 2010; 5: 51-66.
25. Ben Mansour R, Lassoued S, Elgaied A, Haddouk S, Marzouk S, Bahloul Z, et al. Enhanced reactivity to malondialdehydemodified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol 2010; 39: 247-253.
26. Zhang Q, Ye DQ, Chen GP, Zheng Y. Oxidative protein damage and antioxidant status in in systemic lupus erythematosus. Clin Exp Dermatol 2010; 35: 287-294.
27. Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 2010; 62: 2064-2072.